Transactivation/transformation±domain associated protein (TRRAP) is a component of several multiprotein HAT complexes implicated in both transcriptional regulation and DNA repair. We recently identi®ed Trrap, the murine ortholog of TRRAP, as an essential protein implicated in mitotic progression control, although its target genes are not known. In the present study, we analyzed the expression pro®les of Trrap-responsive genes, using cDNA microarray in mitotic cells. From a panel of 17 664 transcript elements, we found that loss of Trrap leads to expression alteration of a large fraction of genes at mitotic stage. Functional classi®cation of these genes indicates that Trrap in¯uences a variety of cellular processes including cell cycle progression, cytoskeleton and cell adhesion, protein turnover, metabolism and signal transduction. The majority (71%) of differentially expressed genes was down-regulated in Trrapde®cient cells, whereas the rest were up-regulated, suggesting that Trrap may also play a role in transcriptional silencing. ChIP analysis revealed that Trrap might regulate gene expression by participating in acetylation of histone H4 and/or H3 depending on target genes and cell cycle stage. Our study indicates that Trrap regulates the expression of a wide range of genes in both quiescence and mitotic stages. Removal of the Trrap protein is associated with both increased and decreased gene expression.
INTRODUCTION
Many important cellular functions, including proliferation, cell cycle progression and checkpoint control, are guided by changes in gene expression and require the coordinated efforts of transcription machinery and chromatin-remodeling activities. Acetylation of speci®c lysine residues within the amino-terminal tails of core histones has been implicated in transcription regulation and other nuclear processes (1, 2) . The level of histone acetylation within a given region of the genome is maintained by varied recruitment of histone acetyltransferases (HATs) and histone deacetylates (HDACs). HAT enzymes are a part of large multiprotein complexes containing adaptors, activators and other associated proteins with unknown functions. It has recently become apparent that many transcription factors, including c-Myc and E2F, overcome the repressive effects of chromatin structure via recruitment of a multi-protein complex containing HAT activity to target genes (3±6).
TRRAP (Transactivation/transformation±domain associated protein), and its yeast ortholog Tra1p, has been identi®ed as a subunit common to several HAT complexes such as PCAF/SAGA (Spt-Ada-Gcn5-acetyl-transferase), Tip60/ NuA4 (nucleosomal acetyl-transferase of histone H4), TATA-binding protein (TBF)-free TAF II -containing complex (TFTC), SILK (novel SAGA-related complex) and SAGA-like (SLIK) complexes (7±15). Mutations within the COOHterminus of Tra1p that disrupt its interaction with HAT complexes result in gene-speci®c transcriptional defects that correlate with lowered promoter-speci®c histone acetylation (9) . Previous studies have established that TRRAP interacts with the transcription factors c-Myc and E2F (12,16±19) . Chromatin immunoprecipitation (ChIP) studies have shown that TRRAP is recruited to the c-Myc target site in chromatin, thereby inducing local histone acetylation (20, 21) . TRRAP participates in the transcriptional regulation of the p53 target gene mdm2 through histone acetylation activity (22) , although the speci®c HAT complex recruited by TRRAP to p53 target sites has not been identi®ed. Altogether, these observations suggest that TRRAP plays a role in transcriptional regulation by modifying local chromatin through histone acetylation.
It remains unknown to what extent different TRRAPcontaining complexes contribute to the transcriptional regulation of different genes and gene families. TRRAP is a subunit of two major classes of HAT complexes with distinct histone speci®city (8, 11, 15) . First class consists of PCAF, GCN5, TFTC and STAGA. These complexes contain the HAT enzymatic subunits PCAF or GCN5 and are shown to acetylate preferentially histone H3. Consistent with the essential role of TRRAP in these complexes, mutants of TRRAP homolog in yeast exhibit compromised H3 acetylation (9) . The second class of TRRAP-containing complexes includes Tip60 complex containing the HAT enzymatic subunit Tip60 with preference for histone H4 (11, 23) . Acetylation of histone H4 at several gene promoters was shown to be mediated by TRRAP (9,20±23) . Therefore, TRRAP may be involved in acetylation of both histone H3 and histone H4 depending on the gene promoter context. However, little is known if a change in preference for histone acetylation occurs at different cell cycle stages.
To study the biological function of TRRAP, we inactivated the murine homolog of TRRAP (Trrap) in embryonic ®broblast cells and in mouse germline using the`conditional' knockout approach (24) . Ablation of Trrap blocked cell proliferation, resulting in the loss of viability of ES cells and embryonic ®broblasts, as well as peri-implantation embryonic lethality in mice. By using an inducible Cre-loxP system, we demonstrated that loss of Trrap causes aberrant mitotic progression and a compromised mitotic checkpoint. Preliminary analysis of expression pro®les of a limited number of genes revealed that Trrap might be important for the transcription of a subset of cell cycle regulators (24) ; however, use of unsynchronized cell populations limited an accurate analysis of the target genes. In order to study physiologically relevant targets of Trrap during mitosis and advance our understanding of the roles of Trrap in chromatin remodeling-mediated transcription, we performed uorescence glass microarray analysis using Trrap-de®cient and Trrap-containing cells.
MATERIALS AND METHODS

Cell culture
Mouse embryonic ®broblasts that are amenable to inducible deletion of Trrap by Cre-ER were described previously (24) . Unless otherwise indicated, the cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), penicillin/streptomycin and glutamine. Deletion of Trrap was induced with 1 mM 4-hydroxy-tamoxifen (OHT) (Sigma, St Louis, MO), as described previously (24) . Progression of the cells through the cell cycle was measured by¯ow cytometric analysis of propidium iodide-stained cells as described previously (24) .
Microarrays, probe preparation and hybridization cDNA microarray slides used in this study were fabricated in the microarray core facility (the Biooptics Department) at the Research Institute of Molecular Pathology (IMP), Vienna, Austria. Brie¯y, the microarrays were constructed using a set of PCR primer pairs speci®c for open reading frames (ORF), which were used to amplify each ORF of the mouse genome, purchased from Research Genetics (Huntsville, AL). Individual PCR products were veri®ed as unique by gel electrophoresis and were puri®ed before spotting on microscope slides using a high-precision robotic gridder. Each slide has 17 664 spots divided into eight blocks, including~8500 unique mouse cDNA sequence and 4000 ESTs. Total mRNAs were isolated from cells using Tri Reagent according to the manufacturer's instructions (Sigma, St Louis, MO). Total RNAs were used to generate Cy3-or Cy5-labeled cDNA by reverse transcription using Cy3-UTP or Cy5-UTP (CyPack PA55322, Amersham Biosciences, Little Chalfont, UK) and the Superscript II (Invitrogen, Carlsbad, CA). The appropriate Cy3-and Cy5-labeled cDNA probes were combined with mouse COT-1 DNA. After denaturation, the probes were added to the microarrays that were placed in a hybridization chamber and incubated overnight (12±20 h) at 50°C.
Data normalization and analysis
After cohybridization to the microarrays,¯uorescence images were captured at both emission wavelengths using a Genepix 4000A¯uorescent scanner (Axon Instruments, Inc., Foster City, CA). The¯uorescent intensities for both dyes (Cy3 and Cy5) were extracted and analyzed using Genepix Pro 3.0 microarray analysis software (Axon Instruments, Inc., Foster City, CA). Signal ratios between samples obtained from Trrap-containing (Cy3) versus Trrap-de®cient (Cy5) cells were obtained after subtracting local background values. Normalization of the Cy3 to Cy5¯uorescent signals was determined by the global median normalization. Spots that were substandard on the scanned image were excluded. As a signi®cance cut-off for the signal:background ratio we used 1.4, i.e. a spot was excluded from further analyses if it had a signal:background ratio <1.4 in both channels. All statistical analyses and evaluations were done using the BioConductor software package. The technical settings (including algorithms) used in our facility were normalized according to standard criteria documented previously (Bioconductor website: http://www.bioconductor.org/ and http://www. bioconductor.org/repository/devel/vignette/marrayNorm.pdf). Primary data on normalization of these genes are available upon request.
Northern blot analysis
Probe preparation for northern blot analysis. Reverse transcription±PCR (RT±PCR) was performed on total RNA prepared from mouse embryonic ®broblasts. Two micrograms of RNA were used for cDNA synthesis using 0.5 mg oligo dT (Amersham Biosciences, Little Chalfont, UK) and 200 U of SuperScriptÔII RNase H ± reverse transcriptase (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. PCR primers for individual genes were designed to generate a DNA fragment 300±700 bp in length. The following primer pairs were used for PCR ampli®cation of RNA probes for each of the tested genes: for the Trrap gene, 5¢-CGGGATCCAT-GAAGCTTCAC-3¢ and 5¢-AACTCTCCAGGGATCTCCAC-3¢; for the antigen identi®ed by monoclonal antibody Ki67 gene (Mki67), 5¢-TAGAGGATCTGCCTGGCTTC-3¢ and 5¢-TGTCCTTGGTTGGTTCCTCC-3¢; for the mammary tumor integration site 6 (Int6), 5¢-TGGATCGGCACCTGGTCTTT-3¢ and 5¢-TCCCTGGTTGACTGCATCTG-3¢; for nucleophosmin, 5¢-CATGAGTCCTCTTAGGCCTC-3¢ and 5¢-TCCAC-TAATGTGCACAGGCC-3¢; for the cyclin A2 gene (Ccna2), 5¢-TCGCTGCATCAGGAAGACCA-3¢ and 5¢-GGCAGGCT-GTTTACTGACTG-3¢; for the eukaryotic translation elongation factor 1 alpha gene (ETEF1a), 5¢-GACACGTAGA-TTCCGGCAAG-3¢ and 5¢-CCGTTCTTGGAGATACCAGC-3¢; for the eukaryotic translation elongation factor 1 beta gene (ETEF1b), 5¢-GGTGCTCAACGATTACCTGG-3¢ and 5¢-GACTTCGCAACAACTGCAGG-3¢; for the RNA polymerase 1±3 gene, 5¢-TCAGGAGCTGGAGAGGAAAG-3¢ and 5¢-TTCCTTGCTTCGCTCAGTGG-3¢; for the thymosin b4 gene, 5¢-ACAAGAGAAGCAAGCTGGCG-3¢ and 5¢-TCA-TCATCTCCCACCCAGCT-3¢; for the ribosomal protein L27A gene (RP L27A), 5¢-TAGGTCTTCTCTTGGCC-TCC-3¢ and 5¢-GACTTCCTCAGTCTGGATGG-3¢; for coatomer protein complex gene, subunit gamma 2 (Copg2), 5¢-CACAAGCAGTCTGACCAAGG-3¢ and 5¢-CCAGCTCTC-TTGCAGTACAG-3¢; for the non-POU domain-containing octamer-binding protein (NonO), 5¢-ATCAGCATCACCAC-CAGCAG-3¢ and 5¢-CCTTCCTCGGTCATCCACAA-3¢; for the syndecan 2 (Sdc2), 5¢-TTGGGCTTGATGGCCTGTGT-3¢ and 5¢-GGCTGCTAGAACTTCTGTCC-3¢; for the FinkelBiskis-Reilly murine sarcoma virus ubiquitously expressed gene (FBR-MuSV), 5¢-ACATGCAGCTCTTTGTCCGC and 5¢-CAACATTGACAAAGCGCCGG; for the Huntingtin interactin protein 2 (HIP-2), 5¢-TCAAGGAGGTGCTGAAGAGC and 5¢-GTTGATGCTCCTCAAGAGGC; for the von HippelLindau binding protein 1 (VHL-BP-1), 5¢-CTGGCCGA-TAACCTGTACTG and 5¢-CATTCCTCACAGTTCTCGG; for the quaking (qk), 5¢-TGGAAACGAAGGAGAAGCCG and 5¢-TGTTGGCGTCTCTGTAGGTG. PCR was performed on 2 ml of cDNA sample using the corresponding primer pairs. The resulting DNA fragment was cloned into the pCR2.1 vector using the TA cloning system (Invitrogen, Carlsbad, CA). After sequence con®rmation by DNA sequencing, all inserts were excised by EcoRI restriction digestion and puri®ed using a gel puri®cation kit (Qiagen, Courtaboeuf, France).
Northern blot analysis. Total RNA (10 mg) was electrophoresed using a 0.9% agarose gel in the presence of 6.7% formaldehyde and transferred to a Hybond N+ membrane (Amersham Biosciences, Little Chalfont, UK) in 10Q SSC. 32 P-labeled probes were made from 20±50 ng of DNA using random priming by the Prime-IT RmT kit according to the manufacturer's instructions (Stratagene, La Jolla, CA). The probe hybridization and stripping buffers and conditions were as instructed by the membrane manufacturer.
Chromatin immunoprecipitation (ChIP) assay
Cells were cultured in 15-cm plates and synchronized as above. Formaldehyde cross-linking and chromatin immunoprecipitations were performed essentially as previously described (21) . Brie¯y, cross-linked cells were harvested in SDS lysis buffer and disrupted by sonication. The lysates were immunoprecipitated with polyclonal antibodies speci®c for either acetylated histone H3 (Upstate Biotech, cat. no. 06-599) or acetylated histone H4 (Upstate Biotech, cat. no. 06-866). Input and immunoprecipitated DNAs were ampli®ed by PCR and the PCR products were analyzed by agarose/ethidium bromide gel electrophoresis. For PCR reactions, we used 1/75 and 1/15 of the immunoprecipitated DNA with anti-acetyl-H3 and anti-acetyl-H4 antibodies, respectively. The primers used for the cyclin A2 promoter were: 5¢-GGGCATAGAGAC-ACGCCTTT-3¢ (CycA2.FOR) and 5¢-GCAGGAGCGTATG-GATCTGA-3¢ (CycA3.REV). The primers for the thymosin b4 promoter were: 5¢-GGCTGTCCACTGGTCTGAAA-3¢ (ThB4-3.FOR) and 5¢-GAACCACATCGATGGCGGAA-3¢ (ThB4-3.REV).
RESULTS
Experimental outline
Trrap is essential for proliferation and is a cofactor for several transcription factors (7±15,24), however its target genes have not been identi®ed. Because loss of Trrap compromises mitotic progression (24) and because several yeast mutants lacking HAT exhibit G2-to-M progression defects (25±28), we sought to identify Trrap target genes associated with cell cycle progression. Cell lines with inducible deletion of Trrap permit us to conditionally inactivate Trrap (24) . Upon addition of the inducer 4-hydroxy-tamoxifen (OHT), the Cre-ER fusion protein is translocated into the cell nucleus, resulting in the deletion of the Trrap gene by Cre recombinase (24) . Ef®ciency of Trrap deletion was monitored by northern blot analysis which showed that Trrap transcripts were virtually absent in OHT-treated cells at the time points used for sample collection (see below).
The experimental outline for cell synchronization is shown in Figure 1A . Trrap-containing cells (pre-incubated without OHT) and Trrap-de®cient cells (pre-incubated with OHT for 24 h) were serum starved for 24 h resulting in an accumulation of G 0 /G 1 (designated as`quiescent cells', Fig. 1B) . To obtain the mitotic population nocodazole (100 ng/ml) was added at 12 h after release from the G 0 /G 1 block and were kept until cells were harvested (designated as`mitotic cells', Fig. 1B ). RNA was extracted from these cells and used to prepare probes to screen cDNA micro-arrays containing 17 664 mouse gene elements (Fig. 1C ). This experimental design allowed us to monitor the expression pro®les of a large number of known genes and as yet unnamed genes (ESTs) as potential targets of Trrap. We performed two independent experiments using identical protocols and the ratios of differentially expressed genes from both experiments showed a good correspondence (Fig. 1D) . The results presented here are from one of the two experiments (Experiment 2).
To control the effect of OHT on gene expression, a cell line transfected with an empty vector (PSG1; see also 24) was treated with or without OHT and gene expression pro®les were analyzed by the cDNA array. With one exception (gene encoding PH domain-containing protein in retina, accession no. AI850671), we observed no signi®cant expression differences between OHT-treated and untreated empty vectortransfected cells, suggesting that OHT did not alter general gene expression levels in these cells.
Expression pro®les of genes in Trrap-de®cient cells at quiescence
To investigate gene expression regulation by Trrap in quiescent state (G 0 /G 1 phase), we ®rst compared gene expression pro®les of Trrap-de®cient and Trrap-containing cells after serum starvation for 24 h (Fig. 1) . Using a criterion difference in expression of at least 2-fold, we found 153 gene expression differences (0.86% of the total 17 664 entities present in the array), representing 67 known genes, between Trrap-containing and Trrap-de®cient cells. One hundred of these entities, representing 46 known genes, were downregulated (Table 1) , and 53 entities, representing 21 known genes, were up-regulated in the Trrap-de®cient cells ( Table 2 ). The down-regulated genes in the Trrap-de®cient cells are involved in a variety of cellular processes, including transcription, protein turnover, cytoskeleton organization, cell cycle, metabolism and adhesion ( Fig. 2A) . The majority of the up-regulated genes are those involved in metabolism, protein turnover and signaling ( Fig. 2A) . 
Differentially expressed genes between Trrap-containing and Trrap-de®cient cells in mitotic cells
Because Trrap-de®cient cells exhibit mitotic progression defects (24) and because mutations in several Trrapcontaining HAT complexes cause G 2 -to-M progression phenotype (24±28), we examined the transcription pro®les of Trrap-de®cient cells after synchronization at mitosis by nocodazole (Fig. 1) . We found that 169 gene elements were down-regulated, representing 113 known genes (Table 3) , whereas 68 gene elements, representing 42 known genes, were up-regulated (Table 4) .
The largest groups of down-regulated genes in mitotic cells were those involved in protein turnover, adhesion, protein transport and folding, cytoskeleton and microtubule-based processes, metabolism and signaling (Table 3 and Fig. 2B) . Only a few cell cycle-associated genes were down-regulated in Trrap-de®cient cells during this stage. Trrap seems to regulate the gene expression of cyclin A2, a major regulator of cell cycle progression through S and G 2 /M phase, but not of cyclin B1 (Table 3 and data not shown). The majority of upregulated genes consisted of those implicated in protein turnover, signaling, metabolism and cell adhesion (Table 4 and Fig. 2B ). It is interesting to note that out of a total of 223 differentially expressed genes, only a small fraction (11 genes) overlapped between quiescent cells and mitotic cells. These results suggest that Trrap regulates distinct sets of genes in mitotic cells compared to quiescent cells.
Veri®cation of microarray results by northern blot analysis
To verify the microarray results using an independent method, we chose 17 differentially expressed genes (Tables 1 and 2 ) for northern blot analysis. In the selection of these genes, we were guided by the criteria of broad representation of different gene classes and expression levels as well as the availability of RNA probes. In all cases, the northern blots con®rmed the microarray results. As shown in Figure 3 , thymosin b4, ribosomal protein L27A (RP L27A), eukaryotic translation Transcripts marked by asterisk were also analyzed by northern blotting.
elongation factor 1 beta (ETEF1b), mammary tumor integration site 6 (Int6), nucleophosmin 1 (nucleoph.1), cyclin A2 (Ccna2), eukaryotic translation elongation factor 1 alpha (ETEF1a), RNA polymerase 1±3 (RNA pol.1±3), FinkelBiskis-Reilly murine sarcoma virus ubiquitously expressed (FBR-MuSV), huntingtin interactin protein 2 (HIP-2), von Hippel-Lindau binding protein 1 (VHL-BP-1), quaking (qk), coatomer protein complex subunit gamma 2 (Copg2), non-POU-domain-containing octamer-binding protein (NonO), syndecan 2 (Sdc2), antigen identi®ed by monoclonal antibody Ki67 (Mki67), followed patterns of expression similar to those seen with the microarrays (Table 5) . Trrap was used as a control to verify deletion of the gene.
Absence of Trrap affects differentially acetylation of histones at the promoters of target genes
Because Trrap is believed to regulate target genes through participation in acetylation of H3 or H4 histones (9, 12, 20, 21) , we attempted to investigate the mode of gene expression regulated by Trrap in these genes. To test whether acetylation of histones H3 or H4 at the gene promoters is affected in cells lacking Trrap during cell cycle progression, we performed ChIP assays on several differentially expressed genes with antibodies speci®c to either acetylated histone (Fig. 4 , and data not shown). While loss of Trrap induced a decrease in both histone H3 and H4 acetylation at the cyclin A2 promoter in the quiescent cells, only acetylation of histone H4 was affected in mitotic cells (Fig. 4B) , suggesting that Trrap is preferentially involved in HAT recruitment to histone H4 during mitosis. The promoter of thymosin b4 exhibited an acetylation defect speci®cally associated with histone H3 in quiescent cells but not in mitotic cells. However, acetylation of histone H4 seemed to be only slightly affected in both quiescent and mitotic cells (Fig. 4C) . These two examples suggest that Trrap modulates acetylation of different histones depending on cell cycle stage, most likely through selective recruitment of speci®c HAT complex.
DISCUSSION
In the present study, we took advantage of genome-wide expression analysis (cDNA microarrays) combined with an inducible deletion technique (Cre/loxP system) and identi®ed genes whose expression is regulated by Trrap during cell cycle progression. Our analysis demonstrates that the expression of many genes is down-regulated due to loss of Trrap, whereas a smaller number of genes are up-regulated. This is consistent with the notion that Trrap is an important regulator of gene transcription throughout cell cycle progression. Functional classi®cation of these genes indicates that Trrap target genes in¯uence a variety of cellular processes including protein turnover, cell cycle progression, DNA repair, metabolism, signal transduction, cytoskeleton and cell adhesion (Fig. 2) . Therefore, the severe and complex effects of Trrap loss on cellular functions are unlikely to be re¯ected by any single target gene. A more likely scenario is that Trrap coordinates expression of a number of gene families, thereby linking transcription, DNA replication, protein turnover and cell cycle control.
TRRAP is a subunit common to many HAT complexes that are believed to facilitate gene transcription (3±6). Two pieces of evidence suggest that Trrap plays a role in progression through cell cycle transitions. First, TRRAP associates with c-Myc and E2F that regulate key genes implicated in G 1 -to-S and G 2 -to-M cell cycle transitions (29±33). Second, Trrapde®cient cells exhibited mitotic defects (24) . Many of the Trrap-regulated genes show clear connections to the main Trrap partners, c-Myc and E2F. Trrap regulates the expression of translation elongation factors, translation initiation factors, transcription elongation factors and ribosomal proteins, groups of genes known to be regulated by c-Myc (30) . Therefore, some important effects of c-Myc on cells may be mediated by Trrap. Furthermore, the Trrap-regulated genes identi®ed in this study function in DNA replication, apoptosis and DNA repair, cellular processes known to be dependent on E2F function (33, 34) . Despite the fact that Trrap interacts with c-Myc and E2F, many Trrap-regulated genes do not show an obvious connection to the main outcome of c-Myc and E2F activities Figure 3 . Con®rmation of differentially expressed genes in microarray analysis by northern blot analyses. Ten micrograms of total RNA was used for each sample of the 17 differentially expressed genes. The blots were reused by stripping off the probes after each hybridization. The following probes were used: (A) thymosin b4; RP L27A (ribosomal protein L27A); (B) ETEF 1b (eukaryotic translation elongation factor 1 beta 2); Int6 (mammary tumor integration site 6); nucleoph. 1 (nucleophosmin 1); Ccna2 (cyclin A2); (C) ETEF 1a (eukaryotic translation elongation factor 1 alpha 1); RNA pol. 1±3 (RNA polymerase 1±3); Trrap; (D) FBR-MuSV (Finkel-Biskis-Reilly murine sarcoma virus ubiquitously expressed); HIP-2 (huntingtin interactin protein 2); VHL-BP-1 (von Hippel-Lindau binding protein 1); qk (quaking); (E) Copg2 (coatomer protein complex, subunit gamma 2); NonO (non-POU-domain-containing, octamer-binding protein); Sdc2 (syndecan 2); (F) Mki67 (antigen identi®ed by monoclonal antibody Ki67). RNA loading was checked by non-speci®c cross-reacting antigen (NCA) probe and ethidium bromide staining of the gels (18 S rRNA and 28S rRNA). 30, 33, 34) . For example, Myc-mediated apoptosis appears to be Trrap independent (17, 35) . Thus the sum of the effects at the transcriptional level seen with loss of c-Myc and E2F appears to be less than the overall effects of Trrap loss, suggesting that Trrap functions in multiple cellular processes that only partly overlap with those of c-Myc and E2F. Consistent with this may be the observation that Trrapde®cient cells display a more severe phenotype than those of cells lacking either c-Myc and E2F1 alone (24,36±38) .
Nucleic Acids
Since TRRAP interacts with many chromatin-remodeling complexes (7±15), loss of Trrap probably affects recruitment of HAT complexes to the promoter of these genes. This alteration would inevitably affect promoter-speci®c chromatin-modifying activities, resulting in compromised gene expression. Indeed, in mitotic cells, Trrap appears to be involved in speci®c acetylation of histone H4, consistent with the previous observations that Trrap recruits HAT complex with af®nity towards histone H4 (20, 21, 23) . However, in quiescent cells, Trrap may be involved in the regulation of the promoters of differentially expressed genes through modi®c-ation of both histone H3 and H4 (cyclin A2), or speci®cally through modi®cation of H3 (thymosin b4). Interestingly, although acetylation of histone H3 at cyclin A2 promoter is decreased in Trrap-de®cient cells in quiescent state (Fig. 4B) , we observed no apparent changes in cyclin A2 expression (Fig. 3B) . This may be due to virtually undetectable levels of cyclin A2 in quiescent cells. Further studies are needed to clarify the lack of association between histone H3/H4 acetylation and gene expression in quiescent state. Nevertheless, our data suggest that Trrap's involvement in acetylation of histone H3 versus histone H4 may depend on cell cycle stage and promoter context.
In addition to direct involvement of Trrap in gene expression through recruitment of HAT complexes to the gene promoter, it is also possible that the loss of Trrap indirectly affects the expression of certain genes due to the compromised expression of critical players that regulate general transcription. Indeed, our study shows that Trrap regulates expression of genes that are themselves involved in regulation of transcription (e.g. RNA polymerase 1±3 and ets homologous factor) ( Tables 1 and 2 ). Finally, due to the limitations of the present approach, it is not possible to determine whether a speci®c Trrap-containing HAT complex is responsible for expression regulation of a particular gene or gene family.
Interestingly, many genes (total of 63 known genes) were up-regulated in Trrap-de®cient cells, suggesting a negative regulation by Trrap. The mechanism of the up-regulation of certain genes in Trrap-de®cient cells is currently unknown. It is possible that loss of Trrap affects the silencing function of certain HAT members, for example some MYST family members (39, 40) . Alternatively, up-regulation of gene expression in the absence of Trrap may be attributable to the compromised expression of putative repressor genes.
In summary, by combining microarray technology and inducible deletion of the Trrap gene in quiescent and mitotic cells this study represents an initial attempt to identify the multiple pathways regulated by Trrap. Full documentation on genome-wide expression pattern regulated by Trrap would provide information on precise cellular pathways involving Trrap and chromatin remodeling in controlling cell cycle progression, cell proliferation and checkpoints. 
